Research letterAssociation between bullous pemphigoid and psoriasis: A case-control study
References (5)
- et al.
Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases
J Am Acad Dermatol
(2015) - et al.
Incidence and mortality of bullous pemphigoid in France
J Invest Dermatol
(2012)
Cited by (28)
Neutrophil-rich, noncollagenous 16A domain-negative bullous pemphigoid associated with psoriasis
2021, JAAD Case ReportsCitation Excerpt :The association between psoriasis and BP has been described in several studies,2 and BP is 3.05 times more likely to develop in psoriatic patients than in matched controls. Notably, psoriasis preceded the development of BP in all patients in a case-control study.10 Additional reports of NC16A domain-negative BP and concurrent psoriasis have been documented in the literature.1,7
A new eruption of bullous pemphigoid within psoriatic plaques following cyclosporine withdrawal
2021, JAAD Case ReportsCitation Excerpt :Autoantibody complement fixation leads to dermal inflammatory infiltrate with C3 and IgG deposition in the BMZ and formation of tense blisters.2 Multiple case-control studies have demonstrated an increased prevalence of BP in psoriasis patients compared with controls.2,3 Although isolated BP typically presents after the age of 70, it often develops earlier in patients with a history of psoriasis.3
Dermatitis Herpetiformis and Celiac Disease Increase the Risk of Bullous Pemphigoid
2019, Journal of Investigative DermatologyCitation Excerpt :However, due to its rapid effect on pruritus, dapsone is frequently used in the initiation of therapy and in patients whose symptoms persist despite the gluten-free diet (Bolotin and Petronic-Rosic, 2011b; Reunala et al., 2015; Collin et al., 2017). Neurologic conditions are well known to be associated with BP, and psychiatric diseases, psoriasis, hypertension, hematologic malignancies, and diabetes have also been reported as comorbidities of BP (Atzmony et al., 2017; Chen et al., 2011; Kibsgaard et al., 2017; Kridin and Bergman, 2017; Schulze et al., 2015; Sim et al., 2017). DH is associated with type I diabetes, thyroid diseases, and other autoimmune diseases (Bolotin and Petronic-Rosic, 2011a; Collin et al., 2017).
Psoriasiform and lichenoid eruptions as a potential harbinger of bullous dermatoses in the setting of immune checkpoint inhibitors: a case series
2023, International Journal of Dermatology
Funding sources: None.
Conflicts of interest: None declared.